Improved Outcomes Using Tacrolimus/Sirolimus for Graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis

Allogeneic hematopoietic cell transplantation (HCT) using reduced intensity conditioning (RIC) regimens is a potentially curative treatment for patients (patients) with myelofibrosis (MF), as we (1) and others have reported. Non-relapse mortality (NRM) from Graft vs. Host Disease (GVHD) and other co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Snyder, David S., Palmer, Joycelynne, Gaal, Karl, Stein, Anthony S., Pullarkat, Vinod, Sahebi, Firoozeh, Vora, Nyana, Nakamura, Ryotaro, Forman, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819616/
https://ncbi.nlm.nih.gov/pubmed/19786111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.09.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars